CVS HEALTH SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KNov. 4, 2026, 6:34 a.m. ETView on SEC.gov
Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedCVS Health Announces Plan to Separate Into Two Companies, Expects Completion in First Half of 2028, and Raises 2026 Guidance
8-KNov. 4, 2026, 6:31 a.m. ETView on SEC.gov Our explainer
Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedCVS Health Q3 2026 adjusted EPS of $2.09 beats $1.65 consensus; full-year adjusted EPS guidance raised to at least $8.20 from $7.90-$8.10
8-KAug. 17, 2026, 4:19 p.m. ETView on SEC.gov
Departure/appointment of directors or officers · Regulation FD disclosure · Financial statements and exhibits
8-KAug. 5, 2026, 6:32 a.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits